PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 139 filers reported holding PRINCIPIA BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $48,978,000 | -4.6% | 819,160 | -5.3% | 0.12% | -18.3% |
| Q1 2020 | $51,364,000 | +87.5% | 865,000 | +73.0% | 0.15% | +128.4% |
| Q4 2019 | $27,390,000 | +142.5% | 500,000 | +25.0% | 0.07% | +139.3% |
| Q3 2019 | $11,296,000 | -31.9% | 400,000 | -20.0% | 0.03% | -31.7% |
| Q2 2019 | $16,595,000 | -30.3% | 500,000 | -28.6% | 0.04% | -31.7% |
| Q1 2019 | $23,800,000 | +24.1% | 700,000 | 0.0% | 0.06% | +13.2% |
| Q4 2018 | $19,173,000 | +118.7% | 700,000 | +133.3% | 0.05% | +165.0% |
| Q3 2018 | $8,766,000 | – | 300,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,996,588 | $56,384,000 | 17.05% |
| Samsara BioCapital, LLC | 383,480 | $10,829,000 | 7.37% |
| Sofinnova Investments, Inc. | 1,417,258 | $40,023,000 | 3.62% |
| Cormorant Asset Management, LP | 1,341,896 | $37,895,000 | 2.31% |
| Orbimed Advisors | 1,605,713 | $45,345,000 | 0.86% |
| Redmile Group, LLC | 790,006 | $22,310,000 | 0.75% |
| PFM Health Sciences, LP | 559,553 | $15,802,000 | 0.47% |
| RTW INVESTMENTS, LP | 270,948 | $7,652,000 | 0.46% |
| Baker Brothers Advisors | 1,654,029 | $46,710,000 | 0.32% |
| UNIVERSITY OF NOTRE DAME DU LAC | 24,572 | $694,000 | 0.21% |